Unforgettable for the first time.
Release time:
2022-06-21
There are many firsts in my life, the first self-reliance, the first night walk, the first cooking ... But I only remember this time, and it is deep in my mind, the first time in my life to be a mother.
2021 7 12 19 45 , this time point I will never forget in my life. Due to the large size of the fetus and narrow pelvis, the pain lasted for nearly 4 hours, the high fever did not subside, the fetus did not enter the basin, and the natural birth was changed to caesarean section. When I was pushed into the operating room and onto the operating bed, I was shivering, not knowing whether it was because of fear or cold. A doctor was afraid that I would be pressed to death. The anesthesiologist asked me to curl up hard and stick a long needle into my waist. After a while, my lower body was unconscious and my brain was still awake. The reaction of anesthesia made me vomit all the time. I heard the sound of the knife on my stomach, but I was blocked by the green cloth in front of me and couldn't see anything. After that, I felt something pulling out of my stomach, and the machine sucking amniotic fluid made a purring sound. After a while, the child came out. When he pulled it out, he felt that his intestines and stomach had fallen down. Wow! Finally freed.
just heard the doctor say it was a big fat boy and was immediately pushed out of the operating room. When I got to the ward, the nurse came to press my stomach and pressed it three or four times. It was as painful as if I had been stabbed with a knife. As a result, I was afraid when I saw the nurse checking it. I covered my stomach and said not to press it again. The nurse smiled and said not to press it again. In order to avoid the uterine adhesion of the parturient, the doctor asked to get out of bed and walk for the first time after delivery. When I took the first step, I was so painful that I doubted my life. Tears swirled repeatedly in my eyes. Obviously, it was only a few steps away from the bathroom, but it seemed to be thousands of miles away.
Giving birth is the bravest thing I have ever done in my life, and it is also the pain I will never forget in my life. As a mother these days, I realize more and more that it is not easy to be a mother, but seeing the healthy growth of children, I feel that everything is worth it. I remember when mother and son met for the first time, his face was red and crying. I was at a loss and in a hurry. I don't know where to start changing diapers for the first time. It took me half an hour to use up a pack of wet wipes. Although it was clumsy, it was also very happy. It is said that one hour after delivery is the golden time for the baby to suck milk. It is very beneficial for the mother to start sucking milk as soon as possible. However, due to my fever before delivery and after delivery, the doctor did not allow me to breastfeed until the third day after delivery, which led to a long milk chase during the whole month. Papaya Chicken Soup, Liquor Eggs, Carp Soup, Peanut Pig Foot Soup Soup Soup Soup Soup Soup Soup Soup ... , blocked milk and broken skin. Every day, my clothes were wet, and I woke up countless times in the middle of the night to feed him. I collapsed to doubt life, but I could only grind my teeth and insist. No one could replace breastfeeding. Don't you regret it after you ask me? I don't regret it, no matter how hard it is, because every time I see my baby drinking milk with full concentration, I suddenly look up and see my grin, and my heart is sweet in an instant.
Time is fleeting. Before you know it, the baby is almost one year old. You are no longer the silly little baby. Now you are beginning to have your own independent thinking and small temper. One skill is waiting for you to dig and master. The long road of life is waiting for you to embark on the journey.
(Gao Youzhi)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31